1. Bivalirudin during percutaneous coronary intervention plus high-dose infusion after demonstrated decreased all-cause mortality compared to heparin monotherapy. 2. Risk ...
1. Patients undergoing percutaneous coronary intervention (PCI) mainly via radial approach receiving either bivalirudin or heparin, in addition to P2Y12 ...
1. Acute coronary syndrome (ACS) patients requiring percutaneous coronary intervention (PCI) who received either heparin or bivalirudin were not significantly ...
Image: PD In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the ...
Image: PD 1. Bivalirudin, initiated during transport for primary PCI in patients with STEMI, improved 30-day clinical outcomes with a ...
